Primary Cilia Are Lost in Preinvasive and Invasive Prostate Cancer

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Hassounah, Nadia B ^a   Nagle, Ray ^b   Saboda, Kathylynn ^a   Roe, Denise J ^a   Dalkin, Bruce L ^d   McDermott, Kimberly M ^a,b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EUKARYOTIC FLAGELLUM; HUMAN; HUMAN TISSUE; MALE; PERINEURAL INVASION; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION;

AGED; BETA CATENIN; CELL MOVEMENT; CELL NUCLEUS; CILIA; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-5; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 84879755092     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068521     Document Type: Article

References (45)

1. Pazour GJ, Agrin N, Leszyk J, Witman GB, (2005) Proteomic analysis of a eukaryotic cilium. Journal of Cell Biology 170: 103-113.
2. Corbit KC, Shyer AE, Dowdle WE, Gaulden J, Singla V, et al. (2008) Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms (vol 10, pg 70, 2008). Nat Cell Biol 10: 497-497. doi:10.1038/ncb0408-497a.
3. Lancaster MA, Schroth J, Gleeson JG, (2011) Subcellular spatial regulation of canonical Wnt signalling at the primary cilium. Nat Cell Biol 13: 700-U173. PubMed: 21602792.
4. Lancaster MA, Gleeson JG, (2009) The primary cilium as a cellular signaling center: lessons from disease. Curr Opin Genet Dev 19: 220-229. doi:10.1016/j.gde.2009.04.008. PubMed: 19477114.
5. Han YG, Kim HJ, Dlugosz AA, Ellison DW, Gilbertson RJ, et al. (2009) Dual and opposing roles of primary cilia in medulloblastoma development. Nat Med 15: 1062-U1114. doi:10.1038/nm.2020. PubMed: 19701203.
6. Wong SY, Seol AD, So PL, Ermilov AN, Bichakjian CK, et al. (2009) Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med 15: 1055-U1109. doi:10.1038/nm.2011. PubMed: 19701205.
7. Yuan K, Frolova N, Xie Y, Wang D, Cook L, et al. (2010) Primary Cilia Are Decreased in Breast Cancer: Analysis of a Collection of Human Breast Cancer Cell Lines and Tissues. J Histochem Cytochem 58: 857-870. doi:10.1369/jhc.2010.955856. PubMed: 20530462.
8. Schraml P, Thoma CR, Boysen G, Struckmann K, Krek W, Moch H, (2009) Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Mod Pathol 22: 31-36. PubMed: 18660794.
9. Kim J, Dabiri S, Seeley ES, (2011) Primary Cilium Depletion Typifies Cutaneous Melanoma In Situ and Malignant Melanoma. PLOS ONE 6: e27410. PubMed: 22096570.
10. Seeley ES, Carrière C, Goetze T, Longnecker DS, Korc M, (2009) Pancreatic Cancer and Precursor Pancreatic Intraepithelial Neoplasia Lesions Are Devoid of Primary Cilia. Cancer Res 69: 422-430. doi:10.1158/0008-5472.CAN-08-1290. PubMed: 19147554.
11. SA G, BN R, PS B, BQ H, GB G, et al. (2013). p. HDAC6 inhibition restores ciliary expression and decreases tumor growth. Cancer Research.
12. Epstein JI, Allsbrook WC, Amin MB, Egevad LL, Comm IG, (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29: 1228-1242. doi:10.1097/01.pas.0000173646.99337.b1. PubMed: 16096414.
13. Pan J, Snell W, (2007) The primary cilium: Keeper of the key to cell division. Cell 129: 1255-1257. doi:10.1016/j.cell.2007.06.018. PubMed: 17604715.
14. Scholzen T, Gerdes J, (2000) The Ki-67 protein: From the known and the unknown. J Cell Physiol 182: 311-22. PubMed: 10653597.
15. Long RM, Morrissey C, Fitzpatrick JM, Watson RW, (2005) Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies. Clin Sci 108: 1-11. PubMed: 15384949.
16. Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM, et al. (1992) Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 52: 6182-7. PubMed: 1384957.
17. van Leenders GJ, Aalders TW, Hulsbergen-van de Kaa CA, Ruiter DJ, Schalken JA, (2001) Expression of basal cell keratins in human prostate cancer metastases and cell lines. J Pathol 195: 563-70. PubMed: 11745692.
18. de Medina SGD, Salomon L, Colombel M, Abbou CC, Bellot J, et al. (1998) Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer. Hum Pathol 29.
19. Hanahan D, Weinberg RA, (2011) Hallmarks of Cancer: The Next Generation. Cell 144: 646-74. PubMed: 21376230.
20. Goetz SC, Anderson KV, (2010) The primary cilium: a signalling centre during vertebrate development. Nat Rev Genet 11: 331-344. doi:10.1038/nrg2774. PubMed: 20395968.
21. Nusse R, (2005) Wnt signaling in disease and in development. Cell Res 15: 28-32. doi:10.1038/sj.cr.7290260. PubMed: 15686623.
22. Chai H, Brown RE, (2009) Field Effect in Cancer-An Update. Ann Clin Lab Sci 39: 331-337. PubMed: 19880759.
23. Kapoor A, (2012) Benign prostatic hyperplasia (BPH) management in the primary care setting. Can J Urol 19 (Suppl 1):: 10-7. PubMed: 23089343.
24. Zhang J, Lipinski RJ, Gipp JJ, Shaw AK, Bushman W, (2009) Hedgehog pathway responsiveness correlates with the presence of primary cilia on prostate stromal cells. BMC Dev Biol 9: 50-. PubMed: 19811645.
25. Ohtsuki Y, Dmochowski L, (1979) Fine structure of single cilium in human prostatic neoplasia. J Clin Electron Microsc 12: 81-90.
26. Whitaker HC, Girling J, Warren AY, Leung H, Mills IG, et al. (2008) Alterations in beta-catenin expression and localization in prostate cancer. Prostate 68: 1196-1205. doi:10.1002/pros.20780. PubMed: 18459111.
27. Assikis VJ, Do KA, Wen S, Wang X, Cho-Vega JH, et al. (2004) Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potential. Clin Cancer Res 10: 6770-6778. doi:10.1158/1078-0432.CCR-04-0275. PubMed: 15501953.
28. Arenas MI, Romo E, Royuela M, Fraile B, Paniagua R, (2000) E-, N- and P-cadherin, and alpha-, beta- and gamma-catenin protein expression in normal, hyperplastic and carcinomatous human prostate. Histochem J 32: 659-667. doi:10.1023/A:1004111331752. PubMed: 11272805.
29. Horvath LG, Henshall SM, Lee CS, Kench JG, Golovsky D, et al. (2005) Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer. Int J Cancer 113: 415-422. doi:10.1002/ijc.20599. PubMed: 15455387.
30. Bismar TA, Humphrey PA, Grignon DJ, Wang HL, (2004) Expression of beta-catenin in prostatic adenocarcinomas: A comparison with colorectal adenocarcinomas. Am J Clin Pathol 121: 557-563. doi:10.1309/447049GV52H7D258. PubMed: 15080308.
31. Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, et al. (2004) Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: Potential pathogenetic and prognostic implications. Cancer 101: 1345-1356. doi:10.1002/cncr.20518. PubMed: 15316903.
32. Aaltomaa S, Kärjä V, Lipponen P, Isotalo T, Kankkunen JP, et al. (2005) Reduced alpha- and beta-catenin expression predicts shortened survival in local prostate cancer. Anticancer Res 25: 4707-12. PubMed: 16334164.
33. Morita N, Uemura H, Tsumatani K, Cho M, Hirao Y, et al. (1999) E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion. Br J Cancer 79: 1879-83. PubMed: 10206308.
34. Jaggi M, Johansson SL, Baker JJ, Smith LM, Galich A, et al. (2005) Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Urol Oncol 23: 402-406. doi:10.1016/j.urolonc.2005.03.024. PubMed: 16301117.
35. Theiss M, Wirth MP, Manseck A, Frohmüller HG, (1995) Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy. Prostate 27: 13-7. PubMed: 7603912.
36. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, et al. (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294: 433-9. PubMed: 16046649.
37. Sakar I, Harada K-I, Hara I, Eto H, Miyake H, (2004) Prognostic Significance of Capsular Invasion and Capsular Penetration in Japanese Men with Prostate Cancer Undergoing Radical Retropubic Prostatectomy. Urol Oncol 4: 27-30.
38. Morgan TM, Lange PH, Porter MP, Lin DW, Ellis WJ, et al. (2009) Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence. Clin Cancer Res 15: 677-683. doi:10.1158/1078-0432.CCR-08-1754. PubMed: 19147774.
39. Egeberg DL, Lethan M, Manguso R, Schneider L, Awan A, et al. (2012) Primary cilia and aberrant cell signaling in epithelial ovarian cancer. Cilia 1: 15-. PubMed: 23351307.
40. Buschhorn HM, Klein RR, Chambers SM, Hardy MC, Green S, et al. (2005) Aurora-A over-expression in high-grade PIN lesions and prostate cancer. Prostate 64: 341-6. PubMed: 15754349.
41. Willemarck N, Rysman E, Brusselmans K, Van Imschoot G, Vanderhoydonc F, et al. (2010) Aberrant Activation of Fatty Acid Synthesis Suppresses Primary Cilium Formation and Distorts Tissue Development. Cancer Res 70: 9453-62. PubMed: 20889723.
42. Schmidt LJ, Ballman KV, Tindall DJ, (2007) Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride. Prostate 67: 1111-1120. doi:10.1002/pros.20602. PubMed: 17477363.
43. Goeman L, Joniau S, Ponette D, Van der Aa F, Roskams T, et al. (2003) Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer? Prostate Cancer Prostatic Dis 6: 305-310. doi:10.1038/sj.pcan.4500681. PubMed: 14663472.
44. Hassounah NB, Bunch TA, McDermott KM, (2012) Molecular Pathways: The Role of Primary Cilia in Cancer Progression and Therapeutics with a Focus on Hedgehog Signaling. Clin Cancer Res 18: 2429-2435. doi:10.1158/1078-0432.CCR-11-0755. PubMed: 22415315.
45. Karlou M, Lu JF, Wu G, Maity S, Tzelepi V, et al. (2012) Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b. Prostate 72: 1638-47. PubMed: 22457212.